Close Menu

NEW YORK (GenomeWeb News) – Cancer genetic analysis firm Personal Genome Diagnostics today announced it has licensed the exclusive rights to the Digital Karyotyping genome mapping technology from Johns Hopkins University.

The technology was developed by the company's founders, who also hold positions at the university. Under the terms of the deal, PGDx can sublicense the DK technology to third parties. Further details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.